| 27.94 Net Asset Value | +0.76% 1 Day | +36.76% Year-to-Date | Overall Morningstar Rating |
| Health Style or Category | No Load Sales Expenses | 2.22% Expense Ratio | Above Average Morningstar Risk Rating™ |
| 1 month | +5.35% | 3 years | +29.12% | |
| 3 months | +21.00% | 5 years | +14.44% | |
| 1 year | +59.47% | Since inception | +2.41% |
| HCPIX | Category | |
|---|---|---|
| Performance 5-yr return | +14.44% | +12.10% |
| Expense ratio | 2.22% | 1.55% |
| Risk 5 year sharpe ratio | 0.64 | 0.71 |
| Net assets | $14.7M | $1.5B |
| Average market cap | $42.7B | $19.4B |
| Average P/E | 18.7 | 21.6 |
| Portfolio turnover | 253% | 253% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | ProFunds |
| Fund manager & tenure | Hratch Najarian / 1 Years |
| Minimal initial investment | $15,000.00 |
| Minimum IRA investment | $15,000.00 |
| Other | 100.00% |
| U.S. stock | -- |
| International stock | -- |
| Fixed income | -- |
| Cash | -- |
| Healthcare | 99.74% |
| Business service | 0.15% |
| Hardware | 0.11% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| JNJ Johnson & Johnson | 7.85% |
| PFE Pfizer Inc | 7.70% |
| MRK Merck & Co Inc | 5.04% |
| AMGN Amgen Inc | 2.53% |
| BMY Bristol-Myers Squibb Company | 2.28% |
| GILD Gilead Sciences Inc | 2.28% |
| ABBV AbbVie Inc | 2.22% |
| UNH UnitedHealth Group Inc | 2.17% |
| LLY Eli Lilly and Company | 2.11% |
| ABT Abbott Laboratories | 2.05% |
.
